As of 2026-09-15, the Intrinsic Value of Newscope Capital Corporation (PHRM.CN) is -0.30 CAD. This PHRM.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.05 CAD, the upside of Newscope Capital Corporation is -703.61%.
Based on its market price of 0.05 CAD and our intrinsic valuation, Newscope Capital Corporation (PHRM.CN) is overvalued by 703.61%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.30 - -0.30 | -0.30 | -703.61% |
| P/E | (0.00) - (0.07) | (0.00) | -108.5% |
| DDM - Stable | (0.09) - (0.42) | (0.26) | -616.1% |
| DDM - Multi | (0.07) - (0.24) | (0.10) | -308.7% |
| Market Cap (mil) | 4.55 |
| Beta | -1.02 |
| Outstanding shares (mil) | 91.02 |
| Enterprise Value (mil) | 3.76 |
| Market risk premium | 5.10% |
| Cost of Equity | 9.90% |
| Cost of Debt | 5.00% |
| WACC | 6.79% |